Title : Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.

Pub. Date : 2015

PMID : 26131212






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: We found there was a statistically significant association between MTX plasma concentration and the SLCO1B1 rs11045879 CC genotype (P<0.05). Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
2 Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
3 OBJECTIVE: The present study aims to investigate the correlation of polymorphisms of SLCO1B1 gene with the toxicity during therapy with the high-dose methotrexate (MTX) chemotherapy in childhood acute lymphoblastic leukemia. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
4 OBJECTIVE: The present study aims to investigate the correlation of polymorphisms of SLCO1B1 gene with the toxicity during therapy with the high-dose methotrexate (MTX) chemotherapy in childhood acute lymphoblastic leukemia. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens
5 METHODS: We analyzed 2 polymorphisms (rs4149081 and rs11045897) in SLCO1B1 gene in 280 Chinese pediatric B-ALL patients, using MTX plasma concentration as an objective and quantifiable marker of toxicity. Methotrexate solute carrier organic anion transporter family member 1B1 Homo sapiens